Alfa-1 lanac kolagena VII jest protein koji je kod ljudi kodiran genom COL7A1 sa hromosoma 3.[5]

COL7A1
Identifikatori
AliasiCOL7A1
Vanjski ID-jeviOMIM: 120120 MGI: 88462 HomoloGene: 73 GeneCards: COL7A1
Lokacija gena (čovjek)
Hromosom 3 (čovjek)
Hrom.Hromosom 3 (čovjek)[1]
Hromosom 3 (čovjek)
Genomska lokacija za COL7A1
Genomska lokacija za COL7A1
Bend3p21.31Početak48,564,073 bp[1]
Kraj48,595,329 bp[1]
Lokacija gena (miš)
Hromosom 9 (miš)
Hrom.Hromosom 9 (miš)[2]
Hromosom 9 (miš)
Genomska lokacija za COL7A1
Genomska lokacija za COL7A1
Bend9 F2|9 59.63 cMPočetak108,782,654 bp[2]
Kraj108,813,943 bp[2]
Obrazac RNK ekspresije


Više referentnih podataka o ekspresiji
Ontologija gena
Molekularna funkcija peptidase inhibitor activity
GO:0001948, GO:0016582 vezivanje za proteine
serine-type endopeptidase inhibitor activity
vezivanje identičnih proteina
extracellular matrix structural constituent conferring tensile strength
Ćelijska komponenta collagen
endoplasmic reticulum lumen
collagen type VII trimer
GO:0005578 Vanćelijski matriks
extracellular region
basement membrane
COPII-coated ER to Golgi transport vesicle
endoplasmic reticulum-Golgi intermediate compartment membrane
Golđijeva membrana
Vanćelijsko
collagen-containing extracellular matrix
Biološki proces negative regulation of peptidase activity
endodermal cell differentiation
extracellular matrix organization
endoplasmic reticulum to Golgi vesicle-mediated transport
COPII vesicle coating
Ćelijska adhezija
epidermis development
collagen catabolic process
negative regulation of endopeptidase activity
growth plate cartilage chondrocyte morphogenesis
Izvori:Amigo / QuickGO
Ortolozi
VrsteČovjekMiš
Entrez
Ensembl
UniProt
RefSeq (mRNK)

NM_000094

NM_007738

RefSeq (bjelančevina)

NP_000085

NP_031764

Lokacija (UCSC)Chr 3: 48.56 – 48.6 MbChr 9: 108.78 – 108.81 Mb
PubMed pretraga[3][4]
Wikipodaci
Pogledaj/uredi – čovjekPogledaj/uredi – miš

Aminokiselinska sekvenca

uredi

Dužina polipeptidnog lanca je 2.944 aminokiselina, а molekulska težina Da. 295 220[6]

1020304050
MTLRLLVAALCAGILAEAPRVRAQHRERVTCTRLYAADIVFLLDGSSSIG
RSNFREVRSFLEGLVLPFSGAASAQGVRFATVQYSDDPRTEFGLDALGSG
GDVIRAIRELSYKGGNTRTGAAILHVADHVFLPQLARPGVPKVCILITDG
KSQDLVDTAAQRLKGQGVKLFAVGIKNADPEELKRVASQPTSDFFFFVND
FSILRTLLPLVSRRVCTTAGGVPVTRPPDDSTSAPRDLVLSEPSSQSLRV
QWTAASGPVTGYKVQYTPLTGLGQPLPSERQEVNVPAGETSVRLRGLRPL
TEYQVTVIALYANSIGEAVSGTARTTALEGPELTIQNTTAHSLLVAWRSV
PGATGYRVTWRVLSGGPTQQQELGPGQGSVLLRDLEPGTDYEVTVSTLFG
RSVGPATSLMARTDASVEQTLRPVILGPTSILLSWNLVPEARGYRLEWRR
ETGLEPPQKVVLPSDVTRYQLDGLQPGTEYRLTLYTLLEGHEVATPATVV
PTGPELPVSPVTDLQATELPGQRVRVSWSPVPGATQYRIIVRSTQGVERT
LVLPGSQTAFDLDDVQAGLSYTVRVSARVGPREGSASVLTVRREPETPLA
VPGLRVVVSDATRVRVAWGPVPGASGFRISWSTGSGPESSQTLPPDSTAT
DITGLQPGTTYQVAVSVLRGREEGPAAVIVARTDPLGPVRTVHVTQASSS
SVTITWTRVPGATGYRVSWHSAHGPEKSQLVSGEATVAELDGLEPDTEYT
VHVRAHVAGVDGPPASVVVRTAPEPVGRVSRLQILNASSDVLRITWVGVT
GATAYRLAWGRSEGGPMRHQILPGNTDSAEIRGLEGGVSYSVRVTALVGD
REGTPVSIVVTTPPEAPPALGTLHVVQRGEHSLRLRWEPVPRAQGFLLHW
QPEGGQEQSRVLGPELSSYHLDGLEPATQYRVRLSVLGPAGEGPSAEVTA
RTESPRVPSIELRVVDTSIDSVTLAWTPVSRASSYILSWRPLRGPGQEVP
GSPQTLPGISSSQRVTGLEPGVSYIFSLTPVLDGVRGPEASVTQTPVCPR
GLADVVFLPHATQDNAHRAEATRRVLERLVLALGPLGPQAVQVGLLSYSH
RPSPLFPLNGSHDLGIILQRIRDMPYMDPSGNNLGTAVVTAHRYMLAPDA
PGRRQHVPGVMVLLVDEPLRGDIFSPIREAQASGLNVVMLGMAGADPEQL
RRLAPGMDSVQTFFAVDDGPSLDQAVSGLATALCQASFTTQPRPEPCPVY
CPKGQKGEPGEMGLRGQVGPPGDPGLPGRTGAPGPQGPPGSATAKGERGF
PGADGRPGSPGRAGNPGTPGAPGLKGSPGLPGPRGDPGERGPRGPKGEPG
APGQVIGGEGPGLPGRKGDPGPSGPPGPRGPLGDPGPRGPPGLPGTAMKG
DKGDRGERGPPGPGEGGIAPGEPGLPGLPGSPGPQGPVGPPGKKGEKGDS
EDGAPGLPGQPGSPGEQGPRGPPGAIGPKGDRGFPGPLGEAGEKGERGPP
GPAGSRGLPGVAGRPGAKGPEGPPGPTGRQGEKGEPGRPGDPAVVGPAVA
GPKGEKGDVGPAGPRGATGVQGERGPPGLVLPGDPGPKGDPGDRGPIGLT
GRAGPPGDSGPPGEKGDPGRPGPPGPVGPRGRDGEVGEKGDEGPPGDPGL
PGKAGERGLRGAPGVRGPVGEKGDQGDPGEDGRNGSPGSSGPKGDRGEPG
PPGPPGRLVDTGPGAREKGEPGDRGQEGPRGPKGDPGLPGAPGERGIEGF
RGPPGPQGDPGVRGPAGEKGDRGPPGLDGRSGLDGKPGAAGPSGPNGAAG
KAGDPGRDGLPGLRGEQGLPGPSGPPGLPGKPGEDGKPGLNGKNGEPGDP
GEDGRKGEKGDSGASGREGRDGPKGERGAPGILGPQGPPGLPGPVGPPGQ
GFPGVPGGTGPKGDRGETGSKGEQGLPGERGLRGEPGSVPNVDRLLETAG
IKASALREIVETWDESSGSFLPVPERRRGPKGDSGEQGPPGKEGPIGFPG
ERGLKGDRGDPGPQGPPGLALGERGPPGPSGLAGEPGKPGIPGLPGRAGG
VGEAGRPGERGERGEKGERGEQGRDGPPGLPGTPGPPGPPGPKVSVDEPG
PGLSGEQGPPGLKGAKGEPGSNGDQGPKGDRGVPGIKGDRGEPGPRGQDG
NPGLPGERGMAGPEGKPGLQGPRGPPGPVGGHGDPGPPGAPGLAGPAGPQ
GPSGLKGEPGETGPPGRGLTGPTGAVGLPGPPGPSGLVGPQGSPGLPGQV
GETGKPGAPGRDGASGKDGDRGSPGVPGSPGLPGPVGPKGEPGPTGAPGQ
AVVGLPGAKGEKGAPGGLAGDLVGEPGAKGDRGLPGPRGEKGEAGRAGEP
GDPGEDGQKGAPGPKGFKGDPGVGVPGSPGPPGPPGVKGDLGLPGLPGAP
GVVGFPGQTGPRGEMGQPGPSGERGLAGPPGREGIPGPLGPPGPPGSVGP
PGASGLKGDKGDPGVGLPGPRGERGEPGIRGEDGRPGQEGPRGLTGPPGS
RGERGEKGDVGSAGLKGDKGDSAVILGPPGPRGAKGDMGERGPRGLDGDK
GPRGDNGDPGDKGSKGEPGDKGSAGLPGLRGLLGPQGQPGAAGIPGDPGS
PGKDGVPGIRGEKGDVGFMGPRGLKGERGVKGACGLDGEKGDKGEAGPPG
RPGLAGHKGEMGEPGVPGQSGAPGKEGLIGPKGDRGFDGQPGPKGDQGEK
GERGTPGIGGFPGPSGNDGSAGPPGPPGSVGPRGPEGLQGQKGERGPPGE
RVVGAPGVPGAPGERGEQGRPGPAGPRGEKGEAALTEDDIRGFVRQEMSQ
HCACQGQFIASGSRPLPSYAADTAGSQLHAVPVLRVSHAEEEERVPPEDD
EYSEYSEYSVEEYQDPEAPWDSDDPCSLPLDEGSCTAYTLRWYHRAVTGS
TEACHPFVYGGCGGNANRFGTREACERRCPPRVVQSQGTGTAQD

Funkcija

uredi

Ovaj gen kodira alfa lanac kolagena tipa VII. Kolagensko vlakno tipa VII, sastavljeno od tri identična alfa-kolagenska lanca, ograničeno je na baznu zonu ispod slojevitog pločastog epitela. Funkcionira kao vlakno za sidrenje između vanjskog epitela i strome ispod. Mutacije u ovom genu su povezane sa svim oblicima distrofijska epidermolysis bullosa.[7] U odsustvu mutacija, međutim, autoimunski odgovor protiv kolagena tipa VII može dovesti do stečenog oblika ove bolesti koji se naziva epidermolysis bullosa acquisita.[8]

Kolagen tipa VII također nalazi se u retini; njegova funkcija u ovom organu nije poznata.[9]

COL7A1 nalazi se na kratkom kraku hromosoma 3, u regiji 3p21.31. Gen je veličine otprilike 31.000 baznih parova i izvanredan je po ekstremnoj fragmentaciji kodirajuće sekvence na 118 egzona.[10][11] COL7A1 se transkribira iu iRNK od 9.287 baznih parova.[12] U koži, kolagene proteine tipa VII sintetiziraju keratinociti i dermni fibroblasti.[13]

Simbol za ortologni gen kućnog miša je Col7a1.

Klinički značaj

uredi

Nasljedna bolest, epidermolysis bullosa dystrophica, uzrokovana je dominantnim ili recesivnim mutacijama u COL7A1.[14]

Epidermolysis bullosa acquisita uključuje autoimunsku reakciju na ovaj oblik kolagena.[15]

Interakcije

uredi

Pokazalo se da kolagen tipa VII alfa 1 ima interakcije sa lamininom 5[16] i fibronektinom.[17][18]

Također pogledajte

uredi

Reference

uredi
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000114270 - Ensembl, maj 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000025650 - Ensembl, maj 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Parente MG, Chung LC, Ryynänen J, Woodley DT, Wynn KC, Bauer EA, Mattei MG, Chu ML, Uitto J (august 1991). "Human type VII collagen: cDNA cloning and chromosomal mapping of the gene". Proceedings of the National Academy of Sciences of the United States of America. 88 (16): 6931–5. Bibcode:1991PNAS...88.6931P. doi:10.1073/pnas.88.16.6931. PMC 52207. PMID 1871109.
  6. ^ "UniProt, Q02388" (jezik: engleski). Pristupljeno 3. 11. 2021.
  7. ^ Bardhan A, Bruckner-Tuderman L, Chapple IL, Fine JD, Harper N, Has C, et al. (septembar 2020). "Epidermolysis bullosa". Nature Reviews. Disease Primers. 6 (1): 78. doi:10.1038/s41572-020-0210-0. PMID 32973163. S2CID 221861310.
  8. ^ "COL7A1 collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive)". NCBI Entrez Gene database.
  9. ^ Ponsioen TL, van Luyn MJ, van der Worp RJ, van Meurs JC, Hooymans JM, Los LI (septembar 2008). "Collagen distribution in the human vitreoretinal interface". Investigative Ophthalmology & Visual Science. 49 (9): 4089–95. doi:10.1167/iovs.07-1456. PMID 18450587.
  10. ^ Christiano AM, Hoffman GG, Chung-Honet LC, Lee S, Cheng W, Uitto J, Greenspan DS (maj 1994). "Structural organization of the human type VII collagen gene (COL7A1), composed of more exons than any previously characterized gene". Genomics. 21 (1): 169–79. doi:10.1006/geno.1994.1239. PMID 8088784.
  11. ^ "COL7A1 genomic sequence". NCBI Entrez Nucleotide Database. 17. 5. 2004.
  12. ^ "COL7A1 mRNA sequence". NCBI Entrez Nucleotide Database. 15. 9. 1995.
  13. ^ OMIM: COL7A1 -120120
  14. ^ Dang N, Murrell DF (juli 2008). "Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa". Experimental Dermatology. 17 (7): 553–68. doi:10.1111/j.1600-0625.2008.00723.x. PMID 18558993. S2CID 32600295.
  15. ^ Helen Chapel; Mansel Haeney; Siraj Misbah (2006). Essentials of clinical immunology. Wiley-Blackwell. str. 207–. ISBN 978-1-4051-2761-5. Pristupljeno 25. 6. 2010.
  16. ^ Rousselle P, Keene DR, Ruggiero F, Champliaud MF, Rest M, Burgeson RE (august 1997). "Laminin 5 binds the NC-1 domain of type VII collagen". The Journal of Cell Biology. 138 (3): 719–28. doi:10.1083/jcb.138.3.719. PMC 2141627. PMID 9245798.
  17. ^ Lapiere JC, Chen JD, Iwasaki T, Hu L, Uitto J, Woodley DT (novembar 1994). "Type VII collagen specifically binds fibronectin via a unique subdomain within the collagenous triple helix". The Journal of Investigative Dermatology. 103 (5): 637–41. doi:10.1111/1523-1747.ep12398270. PMID 7963647.
  18. ^ Chen M, Marinkovich MP, Veis A, Cai X, Rao CN, O'Toole EA, Woodley DT (juni 1997). "Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin". The Journal of Biological Chemistry. 272 (23): 14516–22. doi:10.1074/jbc.272.23.14516. PMID 9169408.

Dopunska literatura

uredi

Vanjski linkovi

uredi